Skip to content
Clinical ResearchResearch compound

Trenbolone

Strong anabolic steroid that strains the heart, kidneys and blood pressure; only one form (Parabolan) was ever sold as a human medicine, until 1997, and it has no human approval today.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Trenbolone vial

DETAILED OVERVIEW

What is Trenbolone?

Trenbolone is a strong, synthetic anabolic steroid. It was originally developed to increase the muscle mass of cattle. Only one form (Parabolan) was ever sold as a human medicine, until 1997; today it has no human approval. In the European Union it exists only as a veterinary product, in the United States it is a controlled substance, and it is banned in competitive sport all year round.

It is used to gain muscle and strength, but the evidence for this comes mainly from animal studies. The risks are serious: it worsens cholesterol values, raises blood pressure and strains the heart and the kidneys. It does not turn into estrogen, but because of its action similar to a female sex hormone the level of the hormone prolactin rises, which can cause breast growth and erection problems. Most users get severe insomnia and night sweats, and aggression and dependence can also occur. It shuts down the body's own testosterone production, and fertility can take more than a year to recover. In women it can cause irreversible masculinization, and it must not be used in pregnancy.

Mechanism

AR agonist, no aromatization, PR activity

Anabolic:Androgenic

500:500

Half-life

3 d (Acetate), 8 d (Enanthate)

Onset

24-48 h

Legal status

No human Rx, WADA banned

Data console

Lab data

Androgenic:Anabolic500:500
AR bindingAR affinity ~5x testosterone; partial…
Active half-life~24 h free Trenbolone (fast clearance after Ace)
Detection windowUrinary: 4-5 months (trenbolone-glucuronide metabolite, WADA-accredited; IRMS up to 6 months).
Aromatizationnone
Hepatotoxicitylow-moderate

Safety

Side effects, stop signs, contraindications

Side effects · 8

  • Severe cardiovascular strain: drastic HDL drop and LDL rise, marked blood-pressure elevation, increased hematocrit, left-ventricular dysfunction with long-term use.
  • Nephrotoxicity: rising creatinine and falling eGFR reflecting partly direct renal injury (not only added muscle mass); persistent creatinine >1.4 mg/dL is a cycle-stop indication.
  • Prolactin elevation from partial progesterone-receptor agonism: gynecomastia, libido swings, erectile dysfunction, rarely lactation; standby cabergoline advised.
  • Sleep disruption and night sweats: elevated sympathetic tone and CNS stimulation cause severe insomnia and profuse night sweating in a large share of users (often 70-80%).
  • Neuropsychiatric effects: increased aggression, irritability, anxiety and mood instability; AAS dependence can also develop.
  • Strong androgenic effects: acne, increased oil production, scalp hair loss in predisposed men; in women irreversible virilization (voice deepening, hirsutism, clitoral enlargement).
  • HPTA suppression and reduced fertility: endogenous testosterone shuts down, and 19-nor metabolites can prolong spermatogenesis recovery (up to 12+ months).
  • Injection-specific effects: frequent post-injection pain (PIP) with the oil formula, plus the Trenbolone-characteristic "Tren-cough" (brief intense coughing fit after injection, especially with Acetate).

Contraindications · 7

  • Pregnancy and breastfeeding: strong androgenic-progestogenic activity, risk of fetal virilization; absolute contraindication.
  • Androgen-sensitive cancer: prostate or breast carcinoma, where androgen may stimulate tumor growth.
  • Kidney disease or impaired renal function: Trenbolone is nephrotoxic, and damage accelerates with reduced eGFR.
  • Uncontrolled hypertension or existing cardiovascular disease: Tren further raises blood pressure and worsens the lipid profile.
  • Psychiatric instability, anxiety disorder or existing sleep disturbance: Tren-aggression and insomnia aggravate these.
  • Polycythemia (hematocrit >54%): further raising hematocrit poses a thrombosis risk.
  • First AAS cycle, use without a testosterone base, or near-term plans to father a child: Tren is not a beginner compound, and 19-nor metabolites cause prolonged fertility recovery.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Trenbolone?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.